Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

693 trials with published results (15%)

Research Maturity

3052 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.1%

191 terminated out of 4637 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

22%

1036 trials in Phase 3/4

Results Transparency

23%

693 of 3052 completed with results

Key Signals

693 with results94% success191 terminated

Data Visualizations

Phase Distribution

3,639Total
Not Applicable (2026)
Early P 1 (36)
P 1 (282)
P 2 (259)
P 3 (457)
P 4 (579)

Trial Status

Completed3,052
Unknown528
Recruiting359
Terminated191
Not Yet Recruiting174
Active Not Recruiting145

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 3052 completed trials

Clinical Trials (4637)

Showing 20 of 20 trials
NCT07074145Not ApplicableRecruitingPrimary

WEAVE NM: Heart Health and Nutrition for Life

NCT02439775Not ApplicableCompletedPrimary

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

NCT05198674Not ApplicableActive Not RecruitingPrimary

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

NCT07735468Not ApplicableCompletedPrimary

Effects of a 10-Week Zumba Program in Adults With Hypertension

NCT07124728Not ApplicableTerminatedPrimary

Syntrillo Telehealth Stroke Risk Reduction Study

NCT06593119Not ApplicableNot Yet RecruitingPrimary

Tailoring TM-HTN Intervention for Black Patients

NCT07730879Not ApplicableRecruitingPrimary

How Wall Squat Exercise Affects Blood Pressure in People With High Blood Pressure and Treated Sleep Apnea (WALLPRESS)

NCT07735091Not ApplicableNot Yet RecruitingPrimary

A Blood Pressure-Lowering Diet for Preventing and Managing Hypertension

NCT07187596Active Not RecruitingPrimary

Mortality Outcome of Controlled Hypertension

NCT07515443Not ApplicableCompletedPrimary

The Effects of a Commercially Available Synbiotic on the Gut Microbiome and Cardiometabolic Health

NCT05962372Not ApplicableRecruiting

Culturally Adapted Dietary Clinical Trial in PR

NCT00837122CompletedPrimary

Genetics of Type 2 Diabetes in West Africans

NCT06205628Phase 1Active Not RecruitingPrimary

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

NCT07727356Not ApplicableActive Not Recruiting

EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders

NCT07728630RecruitingPrimary

Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Adults With Newly Diagnosed Hypertension

NCT07064473Phase 3Recruiting

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT05873153Not ApplicableCompletedPrimary

A Study of Cardiovascular Disparities in the Greater Mankato Somali Community to Prevent Hypertension

NCT06406192Not ApplicableActive Not Recruiting

Effects of FOR-Care Model on Preventive Medicine

NCT06773299Not ApplicableActive Not Recruiting

Enhancing Intergenerational Health in Nigeria: Peripartum as Critical Life Stage for Cardiovascular Health

NCT05968430Phase 3Active Not RecruitingPrimary

Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

Scroll to load more

Research Network

Activity Timeline